ReviewDiagnostics (Basel, Switzerland)2026
Advances and Opportunities in NIR-II Endoscopy: From Diagnosis to Therapeutic Applications.
Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in NIR-II Fluorescence Laparoscopy for Precision Diagnosis and Theranostics of Urological Oncology.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Endoscopy refers to the minimally invasive optical visualization and examination of internal structures within the body. Its significance lies in diagnosing intraluminal tissue abnormalities and assisting therapeutics, especially in the gastrointestinal tract. However, conventional optical endoscopes are limited by their insufficient penetration depth. Although endoscopic ultrasound achieves deeper penetration of up to 10 cm, it suffers from compromised spatial resolution. Recent advances have expanded the role of endoscopy from basic mucosal visualization to precision diagnostics, therapeutic assistance, and even intelligent, remote-assisted procedures. An emerging modality, second near-infrared window (NIR-II, 1000-1700 nm) endoscopy, offers deep tissue penetration, reduced scattering, and a high signal-to-noise ratio. This review discusses the clinical requirements of endoscopy across screening, diagnostics and therapeutics. It provides a comparative assessment of current methodologies, and a particular focus is placed on discussing the promising developments in NIR-II endoscopy. Furthermore, we investigate the transformative potential of integrating artificial intelligence and fifth-generation wireless networks into endoscopic practice. The continued evolution and clinical translation of these technologies, particularly NIR-II endoscopy, hold the promise to fundamentally enhance precision medicine in gastroenterology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.